Literature DB >> 8186288

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle.

H L Davis1, B A Demeneix, B Quantin, J Coulombe, R G Whalen.   

Abstract

Direct gene transfer into skeletal muscle offers several therapeutic possibilities. We assessed direct intramuscular injection of recombinant plasmids, adenovirus, or retrovirus in normal or regenerating muscles of mice. The incorporation and expression of reporter genes introduced by any of these three vectors is greater in regenerating than in mature muscle. In regenerating muscle, pure DNA and adenovirus result in equivalent numbers of fibers expressing reporter gene (> 10%), but adenovirus also induces considerable cellular infiltration. In mature muscle, recombinant DNA is better than adenovirus. Retrovirus failed to infect mature muscle fibers and was less effective than plasmid DNA or adenovirus in regenerating muscle. The surprisingly high relative efficiency of pure plasmid DNA suggests that this method will provide a simple, safe and viable alternative for gene therapy involving muscle tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8186288     DOI: 10.1089/hum.1993.4.6-733

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  47 in total

Review 1.  Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization.

Authors:  R J Mumper; H C Ledebur
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drug.

Authors:  Jehad Charo; Maria Sundbäck; Ken Wasserman; Anne-Marie T Ciupitu; Babak Mirzai; Ruurd van der Zee; Rolf Kiessling
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.

Authors:  Y Capan; B H Woo; S Gebrekidan; S Ahmed; P P DeLuca
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 4.  Nonviral DNA vectors for immunization and therapy: design and methods for their obtention.

Authors:  Ernesto G Rodríguez
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

5.  Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

Authors:  Vivek Mahajan; Zagit Gaymalov; Daria Alakhova; Richa Gupta; Irving H Zucker; Alexander V Kabanov
Journal:  Biomaterials       Date:  2015-10-09       Impact factor: 12.479

Review 6.  Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals.

Authors:  Félix Recillas-Targa
Journal:  Mol Biotechnol       Date:  2006-11       Impact factor: 2.695

7.  Evaluation of hydrodynamic limb vein injections in nonhuman primates.

Authors:  Julia O Hegge; Christine I Wooddell; Guofeng Zhang; James E Hagstrom; Serge Braun; Thierry Huss; Magdolna G Sebestyén; Marina E Emborg; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

8.  DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.

Authors:  M Mancini; M Hadchouel; H L Davis; R G Whalen; P Tiollais; M L Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

9.  Stability and functional effectiveness of phosphorothioate modified duplex DNA and synthetic 'mini-genes'.

Authors:  S A Ciafrè; M Rinaldi; P Gasparini; D Seripa; L Bisceglia; L Zelante; M G Farace; V M Fazio
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

10.  Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

Authors:  R S McHugh; S N Ahmed; Y C Wang; K W Sell; P Selvaraj
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.